Stem cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells

Current Stem Cell Research & Therapy
Tetsuya IshikawaTakahiro Ochiya

Abstract

Severe hepatic dysfunctions including hepatic cirrhosis and hepatocarcinoma are life-threatening conditions for which effective medical treatments are needed. With the only effective treatment to date being orthotropic liver transplantation, alternative approaches are needed because of the limited number of donors and the possibility of immune-rejection. One alternative is regenerative medicine, which holds promise for the development of a cell-based therapy enabling hepatic regeneration through transplantation of adipose tissue-derived mesenchymal stem cells (AT-MSCs) or hepatocyte-like cells generated from AT-MSCs. When compared with embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, the use of AT-MSCs as regenerative cells would be advantageous in regard to ethical and safety issues since AT-MSCs are somatic cells and have the potential to be used without in vitro culture. These autologous cells are immuno-compatible and exhibit controlled differentiation and multi-functional abilities and do not undergo post-transplantation rejection or unwanted differentiation such as formation of teratomas. AT-MSC-based therapies may provide a novel approach for hepatic regeneration and hepatocyte differentiation and ther...Continue Reading

Citations

Apr 26, 2012·Stem Cells and Development·Qi BaoChristiane J Bruns
Aug 2, 2011·Annual Review of Cell and Developmental Biology·Eugen Nacu, Elly M Tanaka
Jul 1, 2010·Stem Cell Research & Therapy·Jeffrey M GimbleBruce A Bunnell
Oct 26, 2013·Cellular and Molecular Life Sciences : CMLS·Iain R MurrayBruno Péault
May 3, 2014·Experimental Cell Research·Sandra WinklerBruno Christ
Mar 9, 2012·Clinical and Experimental Nephrology·Kengo FuruichiTakashi Wada
Jul 25, 2014·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Rezà F Saidi, Seyed Kamran Hejazi Kenari
Jul 1, 2014·Artificial Cells, Nanomedicine, and Biotechnology·Effat AlizadehSeyed Abolghasem Mohammadi
Oct 8, 2013·The Journal of Surgical Research·Sosuke KomiyamaEigo Otsuji
Jun 7, 2011·Gastroenterología y hepatología·Pau Sancho-Bru
Dec 24, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Chiung-Chyi ShenBai-Shuan Liu
Dec 6, 2011·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Yue YuScott L Nyberg
Jun 30, 2015·Journal of Digestive Diseases·Dan YangMu Han Lü
Apr 7, 2015·Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan·Lihua YangYanqing Liu
Jan 31, 2012·Cellular & Molecular Biology Letters·Xia ChenYingjie Wang
Jan 7, 2015·Regenerative Medicine·Carmen HerenciaJuan R Muñoz-Castañeda
May 15, 2012·Theriogenology·Luis Fernando Malaver-OrtegaPaul J Verma
Feb 11, 2014·Asian Pacific Journal of Tropical Medicine·Da-Ming ZhangJian-Ting Hu
Aug 3, 2016·Tissue & Cell·Neveen A SalemShaimaa A ElShebiney
Feb 10, 2016·Cell Medicine·Yoshitaka MiyamotoShuji Hayashi
Sep 28, 2017·Archives of Plastic Surgery·Chae Min KimDae Hyun Lew
May 4, 2011·Molecular Nutrition & Food Research·Srujana RayalamClifton A Baile
Aug 26, 2020·Expert Opinion on Therapeutic Patents·Carlos Roca, Nuria E Campillo
Feb 26, 2015·Journal of Tissue Engineering and Regenerative Medicine·Soumen JanaAmir Lerman
Mar 14, 2017·Stem Cells International·Rokhsareh Rohban, Thomas Rudolf Pieber
Aug 6, 2020·Surgery Today·Yu SaitoMitsuo Shimada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.